Drugs / Melitracen

Trials 4 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT03205228 Jul 2017 → Jun 2018 Mahidol University Completed No outcome recorded
Phase 42 trials
Phase 4 NCT06927375 Dec 2024 → Nov 2025 overdue disease of orbital part of eye adnexa Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Recruiting No outcome recorded
Phase 4 NCT04970667 Jan 2018 → Jan 2020 mood disorder Peking University Third Hospital Completed No outcome recorded
Phase not applicable1 trial
NCT05099913 Aug 2020 → Oct 2022 drug-induced mental disorder, dyspepsia, substance withdrawal syndrome RenJi Hospital Unknown No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT01851863 Comparator May 2013 → Jun 2014 depressive disorder, dyspepsia RenJi Hospital Completed No outcome recorded
Phase not applicable1 trial
NCT06756139 Comparator Nov 2024 → Nov 2025 overdue dyspepsia Air Force Military Medical University, China Recruiting No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Melitracen “Flupentixol and MelitracenNCT05099913
5

NCT06927375

NCT04970667

NCT03205228

NCT01851863

NCT06756139

Known as Adelax ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as Melitracen hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as MELITRACEN HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as Melitracene ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as Melitraceno ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as NSC-78229 ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Known as U 24,973A ChEMBL registry synonym — accepted as the source's own label CHEMBL110094
Modality Small molecule CHEMBL110094
Route Oral “Prescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast)” NCT01851863